# Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical Study

> **NCT01082835** · — · UNKNOWN · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 240 (estimated)

## Conditions studied

- Hypertension
- Metabolic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01082835
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2010-07
- **Final completion:** 2010-08
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2010-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082835, "Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01082835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*